EXTERNAL PUBLICATION Association of mirabegron with the risk of arrhythmia in adult patients 66 years or older—a population-based cohort study Tadrous M, Matta R, Greaves S, Herschorn S, Mamdani MM, Juurlink DN, Gomes T. JAMA Intern Med. 2019; 179(10):1436-9. Epub 2019 Jul 15. DOI: https://doi.org/10.1001/jamainternmed.2019.2011 Abstract not available. View full text.
Infographic Mirabegron for overactive bladder does not appear to increase risk of heart events, compared to other drugs